Hepatitis B vaccine.
D002353:Carrier State; D002986:Clinical Trials as Topic; D004306:Dose-Response Relationship, Immunologic; D005260:Female; D005822:Genetic Vectors; D006509:Hepatitis B / Q000276:immunology / Q000517:prevention & control*; D006510:Hepatitis B Antibodies / Q000276:immunology*; D006514:Hepatitis B Surface Antigens / Q000276:immunology; D006801:Humans; D007115:Immunization Schedule; D007116:Immunization, Passive; D009842:Oligopeptides / Q000138:chemical synthesis / Q000276:immunology; D010564:Personnel, Hospital; D011247:Pregnancy; D011994:Recombinant Proteins / Q000276:immunology; D012306:Risk; D013997:Time Factors; D014611:Vaccination; D014616:Vaccinia virus / Q000235:genetics; D014765:Viral Vaccines / Q000276:immunology*
D006510:Hepatitis B Antibodies; D006514:Hepatitis B Surface Antigens; D009842:Oligopeptides; D011994:Recombinant Proteins; D014765:Viral Vaccines